267163
Platinum
wire, diam. 0.127 mm, 99.99% trace metals basis
Synonym(s):
Platinum element, Platinum gray
Sign Into View Organizational & Contract Pricing
All Photos(1)
About This Item
Recommended Products
Quality Level
Assay
99.99% trace metals basis
form
wire
resistivity
10.6 μΩ-cm, 20°C
diam.
0.127 mm
bp
3827 °C (lit.)
mp
1772 °C (lit.)
density
21.45 g/cm3 (lit.)
SMILES string
[Pt]
InChI
1S/Pt
InChI key
BASFCYQUMIYNBI-UHFFFAOYSA-N
Related Categories
Application
Platinum wire may be used as an electrode during various electrochemical studies. It may also be used during the solid state deposition of colorless transparent crystals of a noncentrosymmetric hexaborate, KBOC, on it surface. Platinum wire, as a catalyst may be useful in accelerating the generation of hydrogen from Ni-rich magnesium alloy in NaCl solution.
Quantity
270 mg = 100 cm; 1.3 g = 500 cm
Storage Class Code
13 - Non Combustible Solids
WGK
nwg
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
Wire-like charge transport at near constant bridge energy through fluorene oligomers.
Proceedings of the National Academy of Sciences of the USA, 102(10), 3540-3545 (2005)
K3B6O10Cl: a new structure analogous to perovskite with a large second harmonic generation response and deep UV absorption edge.
Journal of the American Chemical Society, 133(20), 7786-7790 (2011)
Evaluation of a new hydrogen generating system: Ni-rich magnesium alloy catalyzed by platinum wire in sodium chloride solution.
Materials Transactions, 46(12), 2704-2708 (2005)
Journal of biomedical nanotechnology, 9(2), 274-280 (2013-05-01)
Noninvasive molecular fluorescence imaging in vivo which combines Optical imaging with genetic marker technology can real time monitor the development of tumor, through the use of human adenoid cystic carcinoma cell (ACC-M) and lung carcinoma cells SPC-A1 were thansfected by
Japanese journal of clinical oncology, 43(6), 664-668 (2013-04-16)
Interstitial lung disease associated with gefitinib is a critical adverse reaction. When geftinib was administered to EGFR-unknown patients, the interstitial lung disease incidence rate was approximately 3-4% in Japan, and usually occurs during the first 4 weeks of treatment. However
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service